Explore more publications!

Press Releases

AI In Medical Imaging Market To Experience Strong Growth, Projected To Reach US$ 14.83 Billion By 2032
Smart Healthcare Market To Expand From US$ 206 Billion In 2023 To US$ 541 Billion By 2032
Women’s Health Rehabilitation Products Market to Witness Steady Growth, Projected to Reach USD 7.7 Billion by 2032
Virtual Health Service Market To Reach USD 50.9 Billion By 2032, Growing At 22.4% CAGR
Autoimmune Disease Diagnostics Market Set To Achieve USD 10.3 Billion By 2032, Advances In Diagnostic Technologies
Viscosupplementation Market Set To Achieve USD 7,763.6 Million By 2033, Rising Demand For Joint Health Solutions
Martha Barrantes Reveals Practical Tips for Strengthening Financial Health in Emerging Businesses
A clinical genomicist harnesses team-based science to help rare-disease patients

A clinical genomicist harnesses team-based science to help rare-disease patients

Nelipak Healthcare Packaging Derry, Northern Ireland, Receives International Sustainability and Carbon Certification (ISCC) Plus Certificates
How HealthCare Industry is Leveraging Artificial Intelligence to Revolutionize Diagnostics and Early Disease Detection
COMMUNITY FOUNDATION FOR PALM BEACH AND MARTIN COUNTIES TO HOST 13TH ANNUAL FOUNDERS LUNCHEON ON FEBRUARY 11
ESO and IAED Form Strategic Partnership to Advance Evidence-Based Emergency Dispatch and Response
'Dancing the blues away' seen in brain imaging in people with Parkinson disease, new study finds
Canada’s Most Iconic Christmas Tree Lights Up The 2025 Distillery Winter Village
Avant Technologies and Ainnova Secure Advanced AI Algorithms for Early Detection of Four Additional Diseases in the U.S.
Artificial Intelligence (AI) Redefining Medical Diagnostics Industry That’s Expected to be a $7.2 Billion Market by 2029
Global Ship Lease Reports Results for the Third Quarter of 2025
ESO Appoints Susan Young as Chief Financial Officer
Crawl space encapsulation is increasingly gaining popularity among California homeowners
AB Science provides intitial Phase 1 data for the combination of AB8939 with venetoclax for the treatment of refractory or relapsed acute myeloid leukemia

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions